跳至主要内容
临床试验/JPRN-UMIN000030939
JPRN-UMIN000030939已完成未知

Multicenter, prospective observational study to identify peripheral blood-derived epigenome markers correlated with blood trough value and adverse events of afatinib in EGFR mutation-positive non-small cell lung cancer patients - Afatinib PEGx study

Toshiyuki Sawa Gifu City Hospital0 个研究点目标入组 11 人开始时间: 2018年1月27日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
11

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Idiopathic pulmonary fibrosis, interstitial pneumonia, pneumoconiosis, active radiation pneumonitis, drug pneumonia, etc. are complicated Active other malignancy HBs antigen positive HBs or HBc antibody positive and HBV-DNA positive HIV or HCV carrier Adjuvant chemotherapy Infection to need to treat with antibiotics or antifungal agent via intravenous administration Not obtain the consent of taking the sample Serious psychiatric disorder Women who are pregnant, nursing, or who plan to become pregnant and Men who plan to father a child while in this study.

研究者

发起方
Toshiyuki Sawa Gifu City Hospital

相似试验